<DOC>
	<DOCNO>NCT02309320</DOCNO>
	<brief_summary>The primary objective study investigate safety tolerability ALX-0171 . The secondary objective evaluate clinical effect ALX-0171 explore pharmacodynamics ( PD ) systemic pharmacokinetics ( PK ) ALX-0171 .</brief_summary>
	<brief_title>A Multicentre Study Otherwise Healthy Infants Toddlers Hospitalised For Diagnosed With RSV Lower Respiratory Tract Infection Evaluate Safety , Tolerability , Clinical Activity ALX-0171</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<criteria>1 . Subject otherwise healthy , hospitalise clinically diagnose RSV LRTI ( Lower Respiratory Tract Infection ) 2 . Subject appearance upper low respiratory tract infection symptom likely related RSV 3 . Subject positive RSV diagnostic test 4 . Others define protocol 1 . Subject history wheeze 2 . Subject know significant comorbidities 3 . Subject know immunocompromised 4 . Subject suspect clinically relevant infection RSV 5 . Others define protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>